nsc 607097 has been researched along with noscapine in 1 studies
| Studies (nsc 607097) | Trials (nsc 607097) | Recent Studies (post-2010) (nsc 607097) | Studies (noscapine) | Trials (noscapine) | Recent Studies (post-2010) (noscapine) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 510 | 16 | 191 |
| Protein | Taxonomy | nsc 607097 (IC50) | noscapine (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 2.6 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 8.1773 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.4003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Ding, HF; Lang, L; Liu, G; Sun, SY; Yan, C | 1 |
1 other study(ies) available for nsc 607097 and noscapine
| Article | Year |
|---|---|
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
Topics: CRISPR-Cas Systems; Gene Targeting; Genes; Genes, Reporter; Genetic Engineering; Humans; Internal Ribosome Entry Sites; Transcription, Genetic | 2015 |